002737.SZ
葵花药业
SZSE · Healthcare · C 制造业 · CN
CNY 12.86
−1.38%Margins
Gross margin
44.5%
EBITDA margin
-3.1%
EBIT margin
-7.4%
Net margin
-8.2%
FCF margin
17.4%
-5.2%
Return on equity
-3.8%
Return on assets
-4.5%
Return on invested capital
0.47x
Asset turnover
CNY 551.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026